These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 1746966)
1. [Evaluation of induced hypertension chemotherapy (IHC) in ambulatory cancer patients]. Sato H; Sugiyama K; Ishizuka K; Hoshi M; Urushiyama M Gan To Kagaku Ryoho; 1991 Dec; 18(15):2509-16. PubMed ID: 1746966 [TBL] [Abstract][Full Text] [Related]
2. [Randomized controlled trial of induced hypertension chemotherapy (IHC) using angiotensin II human (TY-10721) in advanced gastric carcinoma (TY-10721 IHC Study Group Report)]. Sato H; Wakui A; Hoshi M; Kurihara M; Yokoyama M; Shimizu H Gan To Kagaku Ryoho; 1991 Mar; 18(3):451-60. PubMed ID: 1900686 [TBL] [Abstract][Full Text] [Related]
3. [Preoperative role of angiotensin II induced hypertension chemotherapy (IHC) in advanced gastric carcinoma]. Sugiyama K; Sato H; Ishizuka K; Hoshi M; Urushiyama M; Wakui A Gan To Kagaku Ryoho; 1992 Feb; 19(2):203-9. PubMed ID: 1736832 [TBL] [Abstract][Full Text] [Related]
4. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer. Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer. Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246 [TBL] [Abstract][Full Text] [Related]
6. [Dose intensity and clinical response in patients with advanced gastric carcinoma treated by induced hypertension chemotherapy]. Sato H; Urushiyama M; Sugiyama K; Ishizuka K; Hoshi M; Wakui A Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):564-9. PubMed ID: 2321982 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
8. [Effects of combination chemotherapy using 5-FU, leucovorin, and CDDP (FLP therapy) for noncurative resected or recurrent stomach cancer in outpatients]. Okugawa T; Onodera S; Rino Y; Okada K; Kobayashi O; Sairenji M; Motohashi H Gan To Kagaku Ryoho; 1994 Jul; 21(8):1193-7. PubMed ID: 8031161 [TBL] [Abstract][Full Text] [Related]
9. A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer. Li M; Zhang J; Wang D; Zhong B; Tucker S; Lu C; Cheng J; Cao C; Xu J; Xu J; Pan H Anticancer Drugs; 2009 Nov; 20(10):941-5. PubMed ID: 19745719 [TBL] [Abstract][Full Text] [Related]
10. [Trial of outpatient anti-cancer chemotherapy with infusion of 5-FU and cisplatin for advanced gastric and colorectal cancers]. Suzuki H; Kanou Y; Ooshima H; Kawase J; Kudou J; Mizuno Y; Matsumoto S Gan To Kagaku Ryoho; 2005 Feb; 32(2):189-93. PubMed ID: 15751631 [TBL] [Abstract][Full Text] [Related]
11. [Quality of life in patients with advanced gastric cancer receiving AO-90, a methionine-free intravenous amino acid solution, with 5-fluorouracil and mitomycin C]. Kurihara M; Kosaki G; Taguchi T; Akazawa S; Sasaki T; Takahashi H; Onodera T; Endo M; Nakagawara G; Sano K Gan To Kagaku Ryoho; 1995 Jun; 22(7):911-23. PubMed ID: 7793997 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer. Kikuyama S; Inada T; Oyama R; Ogata Y Anticancer Res; 2002; 22(6B):3633-6. PubMed ID: 12552968 [TBL] [Abstract][Full Text] [Related]
13. [Clinical study of ambulatory cancer chemotherapy for recurrent breast cancer]. Takahashi N; Nitta A; Kunii Y; Ota K Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():439-43; discussion 443-4. PubMed ID: 7802447 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer. Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531 [TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer]. Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669 [TBL] [Abstract][Full Text] [Related]
16. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study. Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis]. Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622 [TBL] [Abstract][Full Text] [Related]
18. [Tumor microcirculation and selective enhancement of drug delivery--clinical applications based on pathophysiological experiments]. Sato H; Hori K; Sugiyama K; Tanda S; Sato Y Gan To Kagaku Ryoho; 2000 Jul; 27(8):1191-200. PubMed ID: 10945016 [TBL] [Abstract][Full Text] [Related]
19. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the combination of chemotherapy with etoposide, adriamycin and cisplatin (EAP) in advanced or recurrent gastric cancer]. Terata N; Sano H; Ishibashi H; Tani T; Hanasawa K; Endo Y; Kurumi Y; Shibata J; Kodama M; Tsuji K Gan To Kagaku Ryoho; 1993 Apr; 20(5):611-6. PubMed ID: 8470918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]